Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens

European Journal of Immunology

Volumn 32, Issue 1, 2002, Pages 155-162

  Shi, Yan ^a   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antigen presentation; Cell trafficking; CTL; Dendritic cell; Phagocytosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; IMMUNE SYSTEM; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; LYMPHATIC DRAINAGE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR; VIRUS INFECTION;

3T3 CELLS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP120; HUMANS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SOLUBILITY;

EID: 0036146272     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO;2-P     Document Type: Article

References (36)

1. Dendritic cells and the control of immunity
2. The dendritic cell system and its role in immunogenicity
3. Cytotoxic T cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
4. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and - Antigen presentation
5. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
6. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
7. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
8. Developmental regulation of MHC class II transport in mouse dendritic cells
9. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
10. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis
11. Presentation of exogenous antigen with class I major histocompatibility complex molecules
12. A new foreign policy: MHC class I molecules monitor the outside world
13. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
14. Approaching the asymptote? Evolution and revolution in immunology
15. Innate immune recognition: Mechanisms and pathways
16. Cellular response to double-stranded RNA
17. Viral double-stranded RNA, cytokines, and the flu
18. Natural adjuvants: Endogenous activators of dendritic cells
19. Tolerance, danger, and the extended family
20. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses
21. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
22. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
23. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
24. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells
25. + cells in vivo
26. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
27. Use of plasmid DNA for direct gene transfer and immunization
28. + T cell tolerance induction versus priming is independent of the rate and number of cell divisions
29. Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens
30. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
31. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory
32. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
33. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor
34. Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma
35. Central role for interferon-gamma receptor in the regulation of renal MHC expression
36. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway